Live Breaking News & Updates on Potlight Phase 3 Trial
Stay updated with breaking news from Potlight phase 3 trial . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Emerging treatments, particularly claudin 18.2, a potential new biomarker in the HER2-negative gastric and gastroesophageal junction cancer space, were highlights of the 2023 ASCO Gastrointestinal Cancers Symposium. ....